Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors.
Bench-to-bedside Translation
EV Biodistribution Kinetics
Intraoperative Imaging
Toxicology
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2024
2024
Historique:
received:
20
05
2024
accepted:
14
08
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
21
10
2024
Statut:
epublish
Résumé
Extracellular vesicles (EVs) derived from the plasma of oncological patients exhibit significant tumor-targeting properties, unlike those from healthy individuals. We have previously shown the feasibility of formulating the near-infrared (NIR) fluorescent dye indocyanine green (ICG) with patient-derived extracellular vesicles (PDEVs) for selective delivery to neoplastic tissue. This staining protocol holds promise for clinical application in intraoperative tumor margin imaging, enabling precise neoplastic tissue resection. To this end, we propose the ONCOGREEN protocol, involving PDEV isolation, ICG loading, and reinfusion into the same patients.
Identifiants
pubmed: 39431003
doi: 10.7150/thno.98671
pii: thnov14p6301
pmc: PMC11488097
doi:
Substances chimiques
Indocyanine Green
IX6J1063HV
Fluorescent Dyes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6301-6318Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.